Global Tuberculosis Vaccine Treatment Market Research Report 2023(Status and Outlook)


Attention: There is an updated edition available for this report.

Global Tuberculosis Vaccine Treatment Market Research Report 2023(Status and Outlook)



Report Overview

Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.

Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.

In the last several years, global market of Tuberculosis Vaccine Treatment developed smoothly, with an average growth rate of 0.73%.

The classification of Tuberculosis Vaccine Treatment includes Immune Vaccine and Therapy Vaccine, and the proportion of Immune Vaccine in 2019 is about 99.66%.

Tuberculosis Vaccine Treatment is widely sold through Self-Procurement, UNICEF and Other. The most proportion of Tuberculosis Vaccine Treatment is sold through Self-Procurement, and the proportion in 2019 is 62.14%.

Asia-Pacific is the largest consumption place, with a consumption market share nearly 45% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of 35.66%.

Market competition is intense. Merck, Japan BCG Lab, Serum Institute of India are the leaders of the industry, they occupy the 60% of the market.

The Global Tuberculosis Vaccine Treatment Market Size was estimated at USD 72.00 million in 2022 and is projected to reach USD 87.95 million by 2029, exhibiting a CAGR of 2.90% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Tuberculosis Vaccine Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Tuberculosis Vaccine Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Tuberculosis Vaccine Treatment market in any manner.

Global Tuberculosis Vaccine Treatment Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Merck

Japan BCG Lab

Serum Institute of India

AJ Vaccines

BioFarma

GreenSignal Bio Pharma

China National Biotec

Biomed Lublin

Taj Pharmaceuticals

Ataulpho de Paiva

IVAC

Queen Saovabha Mem. Inst

Microgen

Market Segmentation (by Type)

Immune Vaccine

Therapy Vaccine

Market Segmentation (by Application)

Memory

Foundry

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Tuberculosis Vaccine Treatment Market

Overview of the regional outlook of the Tuberculosis Vaccine Treatment Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

6-month post-sales analyst support

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Tuberculosis Vaccine Treatment Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Tuberculosis Vaccine Treatment
1.2 Key Market Segments
1.2.1 Tuberculosis Vaccine Treatment Segment by Type
1.2.2 Tuberculosis Vaccine Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Tuberculosis Vaccine Treatment Market Overview
2.1 Global Market Overview
2.1.1 Global Tuberculosis Vaccine Treatment Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Tuberculosis Vaccine Treatment Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Tuberculosis Vaccine Treatment Market Competitive Landscape
3.1 Global Tuberculosis Vaccine Treatment Sales by Manufacturers (2018-2023)
3.2 Global Tuberculosis Vaccine Treatment Revenue Market Share by Manufacturers (2018-2023)
3.3 Tuberculosis Vaccine Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Tuberculosis Vaccine Treatment Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Tuberculosis Vaccine Treatment Sales Sites, Area Served, Product Type
3.6 Tuberculosis Vaccine Treatment Market Competitive Situation and Trends
3.6.1 Tuberculosis Vaccine Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Tuberculosis Vaccine Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Tuberculosis Vaccine Treatment Industry Chain Analysis
4.1 Tuberculosis Vaccine Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Tuberculosis Vaccine Treatment Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Tuberculosis Vaccine Treatment Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2018-2023)
6.3 Global Tuberculosis Vaccine Treatment Market Size Market Share by Type (2018-2023)
6.4 Global Tuberculosis Vaccine Treatment Price by Type (2018-2023)
7 Tuberculosis Vaccine Treatment Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Tuberculosis Vaccine Treatment Market Sales by Application (2018-2023)
7.3 Global Tuberculosis Vaccine Treatment Market Size (M USD) by Application (2018-2023)
7.4 Global Tuberculosis Vaccine Treatment Sales Growth Rate by Application (2018-2023)
8 Tuberculosis Vaccine Treatment Market Segmentation by Region
8.1 Global Tuberculosis Vaccine Treatment Sales by Region
8.1.1 Global Tuberculosis Vaccine Treatment Sales by Region
8.1.2 Global Tuberculosis Vaccine Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Tuberculosis Vaccine Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Tuberculosis Vaccine Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Tuberculosis Vaccine Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Tuberculosis Vaccine Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Tuberculosis Vaccine Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Merck
9.1.1 Merck Tuberculosis Vaccine Treatment Basic Information
9.1.2 Merck Tuberculosis Vaccine Treatment Product Overview
9.1.3 Merck Tuberculosis Vaccine Treatment Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck Tuberculosis Vaccine Treatment SWOT Analysis
9.1.6 Merck Recent Developments
9.2 Japan BCG Lab
9.2.1 Japan BCG Lab Tuberculosis Vaccine Treatment Basic Information
9.2.2 Japan BCG Lab Tuberculosis Vaccine Treatment Product Overview
9.2.3 Japan BCG Lab Tuberculosis Vaccine Treatment Product Market Performance
9.2.4 Japan BCG Lab Business Overview
9.2.5 Japan BCG Lab Tuberculosis Vaccine Treatment SWOT Analysis
9.2.6 Japan BCG Lab Recent Developments
9.3 Serum Institute of India
9.3.1 Serum Institute of India Tuberculosis Vaccine Treatment Basic Information
9.3.2 Serum Institute of India Tuberculosis Vaccine Treatment Product Overview
9.3.3 Serum Institute of India Tuberculosis Vaccine Treatment Product Market Performance
9.3.4 Serum Institute of India Business Overview
9.3.5 Serum Institute of India Tuberculosis Vaccine Treatment SWOT Analysis
9.3.6 Serum Institute of India Recent Developments
9.4 AJ Vaccines
9.4.1 AJ Vaccines Tuberculosis Vaccine Treatment Basic Information
9.4.2 AJ Vaccines Tuberculosis Vaccine Treatment Product Overview
9.4.3 AJ Vaccines Tuberculosis Vaccine Treatment Product Market Performance
9.4.4 AJ Vaccines Business Overview
9.4.5 AJ Vaccines Tuberculosis Vaccine Treatment SWOT Analysis
9.4.6 AJ Vaccines Recent Developments
9.5 BioFarma
9.5.1 BioFarma Tuberculosis Vaccine Treatment Basic Information
9.5.2 BioFarma Tuberculosis Vaccine Treatment Product Overview
9.5.3 BioFarma Tuberculosis Vaccine Treatment Product Market Performance
9.5.4 BioFarma Business Overview
9.5.5 BioFarma Tuberculosis Vaccine Treatment SWOT Analysis
9.5.6 BioFarma Recent Developments
9.6 GreenSignal Bio Pharma
9.6.1 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Basic Information
9.6.2 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product Overview
9.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product Market Performance
9.6.4 GreenSignal Bio Pharma Business Overview
9.6.5 GreenSignal Bio Pharma Recent Developments
9.7 China National Biotec
9.7.1 China National Biotec Tuberculosis Vaccine Treatment Basic Information
9.7.2 China National Biotec Tuberculosis Vaccine Treatment Product Overview
9.7.3 China National Biotec Tuberculosis Vaccine Treatment Product Market Performance
9.7.4 China National Biotec Business Overview
9.7.5 China National Biotec Recent Developments
9.8 Biomed Lublin
9.8.1 Biomed Lublin Tuberculosis Vaccine Treatment Basic Information
9.8.2 Biomed Lublin Tuberculosis Vaccine Treatment Product Overview
9.8.3 Biomed Lublin Tuberculosis Vaccine Treatment Product Market Performance
9.8.4 Biomed Lublin Business Overview
9.8.5 Biomed Lublin Recent Developments
9.9 Taj Pharmaceuticals
9.9.1 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Basic Information
9.9.2 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product Overview
9.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product Market Performance
9.9.4 Taj Pharmaceuticals Business Overview
9.9.5 Taj Pharmaceuticals Recent Developments
9.10 Ataulpho de Paiva
9.10.1 Ataulpho de Paiva Tuberculosis Vaccine Treatment Basic Information
9.10.2 Ataulpho de Paiva Tuberculosis Vaccine Treatment Product Overview
9.10.3 Ataulpho de Paiva Tuberculosis Vaccine Treatment Product Market Performance
9.10.4 Ataulpho de Paiva Business Overview
9.10.5 Ataulpho de Paiva Recent Developments
9.11 IVAC
9.11.1 IVAC Tuberculosis Vaccine Treatment Basic Information
9.11.2 IVAC Tuberculosis Vaccine Treatment Product Overview
9.11.3 IVAC Tuberculosis Vaccine Treatment Product Market Performance
9.11.4 IVAC Business Overview
9.11.5 IVAC Recent Developments
9.12 Queen Saovabha Mem. Inst
9.12.1 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Basic Information
9.12.2 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product Overview
9.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product Market Performance
9.12.4 Queen Saovabha Mem. Inst Business Overview
9.12.5 Queen Saovabha Mem. Inst Recent Developments
9.13 Microgen
9.13.1 Microgen Tuberculosis Vaccine Treatment Basic Information
9.13.2 Microgen Tuberculosis Vaccine Treatment Product Overview
9.13.3 Microgen Tuberculosis Vaccine Treatment Product Market Performance
9.13.4 Microgen Business Overview
9.13.5 Microgen Recent Developments
10 Tuberculosis Vaccine Treatment Market Forecast by Region
10.1 Global Tuberculosis Vaccine Treatment Market Size Forecast
10.2 Global Tuberculosis Vaccine Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Tuberculosis Vaccine Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Tuberculosis Vaccine Treatment Market Size Forecast by Region
10.2.4 South America Tuberculosis Vaccine Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Tuberculosis Vaccine Treatment by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Tuberculosis Vaccine Treatment Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Tuberculosis Vaccine Treatment by Type (2024-2029)
11.1.2 Global Tuberculosis Vaccine Treatment Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Tuberculosis Vaccine Treatment by Type (2024-2029)
11.2 Global Tuberculosis Vaccine Treatment Market Forecast by Application (2024-2029)
11.2.1 Global Tuberculosis Vaccine Treatment Sales (K MT) Forecast by Application
11.2.2 Global Tuberculosis Vaccine Treatment Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings